Skip to main content
Premium Trial:

Request an Annual Quote

Bruker MALDI Tissuetyper, MALDI PharmaPulse, and Mycobacteria Library 3.0

Bruker this week launched three new products at the American Society for Mass Spectrometry and American Society for Microbiology conferences.

The Bruker Maldi Tissuetyper application on Bruker rapifleX MALDI-TOF mass spec system is designed for MALDI imaging anatomical pathology research. The solution works up to 20 times faster than traditional MALDI-TOF systems, using Bruker's proprietary smartbeam 3D laser, the company said. This laser is synchronized with the movement of the MALDI target stage, and has a repetition rate of 10 kHz, enabling higher throughput where researchers have dramatically increased flexibility in pixel size or target tissue size. Depending on sample size, typical tissue sections can now be imaged in approximately 30 minutes, while mass spec images from small tissue biopsies are available in a few minutes, the company said.

Meantime, Bruker's MALDI PharmaPulse solution combines Bruker's MALDI-TOF systems with high-throughput screening robotics and automation software from HighRes Biosolutions to help pharmaceutical, biotech, and contract research customers accelerate drug discovery and development.

Finally, Bruker released the 3.0 expansion of its Mycobacteria Library for research use only on the MALDI Biotyper system. The new library now includes 149 different species, enabling significantly improved rapid and accurate identification of almost all described Mycobacteria species, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.